{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:08:38Z","timestamp":1761894518943},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2007]]},"DOI":"10.2169\/internalmedicine.46.6330","type":"journal-article","created":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T05:48:24Z","timestamp":1177998504000},"page":"589-591","source":"Crossref","is-referenced-by-count":12,"title":["Rapidly Progressive Guillain-Barr&amp;eacute; Syndrome Following &lt;i&gt;Escherichia coli&lt;\/i&gt; Infection"],"prefix":"10.2169","volume":"46","author":[{"given":"Yuriko","family":"Kono","sequence":"first","affiliation":[{"name":"General Internal Medicine, Teine Keijinkai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Nishitarumizu","sequence":"additional","affiliation":[{"name":"General Internal Medicine, Teine Keijinkai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Higashi","sequence":"additional","affiliation":[{"name":"Neurology, Nishimaruyama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Funakoshi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Odaka","sequence":"additional","affiliation":[{"name":"Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625, 2002.","DOI":"10.1093\/brain\/awf272"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close association of Guillain-Barr&eacute; syndrome with antibodies to minor monosialogangliosides GM1b and GM1&alpha;. J Neuroimmunol 74: 30-34, 1997.","DOI":"10.1016\/S0165-5728(96)00201-9"},{"key":"3","unstructured":"3. Bolton CF, Young GB. Neurological complications in critically ill patients. In: In: Neurology and General Medicine. 3rd ed. Churchill, Livingstone, 2001: 868-871."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ropper AH. The Guillain-Barr&eacute; syndrome. N Engl J Med 326 (17): 1130-1136, 1992.","DOI":"10.1056\/NEJM199204233261706"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Jacobs BC, Rothbarth PH, van der, Merche FG et al. The spectrum of antecedent infections in Guillain-Barr&eacute; syndrome: a case-control study. Neurology 51: 1110-1115, 1998.","DOI":"10.1212\/WNL.51.4.1110"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barr&eacute; and Fisher syndromes. Lancet Infect Dis 1: 29-37, 2001.","DOI":"10.1016\/S1473-3099(01)00019-6"},{"key":"7","unstructured":"7. Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N. <i>Campylobacter coli<\/i> enteritis and Guillain-Barr&eacute; syndrome: No evidence of molecular mimicry and serological relationship. J Neuro Sci 246: 163-168, 2006."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kusunoki S, Chiba A, Kon K et al. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barr&eacute; syndrome. Ann Neurol 35: 570-576, 1994.","DOI":"10.1002\/ana.410350510"},{"key":"9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","volume":"61","year":"2003","unstructured":"9. Kaida K, Kusunoki S, Kamakura K et al. GalNAc-GD1a in human peripheral nerve. Neurology 61: 465-470, 2003.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yoshino H, Utsunomiya I, Taguchi K et al. GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots. Brain Res 1057: 177-180, 2005.","DOI":"10.1016\/j.brainres.2005.07.063"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625, 2002.","DOI":"10.1093\/brain\/awf272"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/46\/9\/46_9_589\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T16:15:14Z","timestamp":1556381714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/46\/9\/46_9_589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.46.6330","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}